These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2666363)

  • 61. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
    Clahsen PC; van de Velde CJ; Julien JP; Floiras JL; Delozier T; Mignolet FY; Sahmoud TM
    J Clin Oncol; 1996 Mar; 14(3):745-53. PubMed ID: 8622020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles.
    Tancini G; Bonadonna G; Valagussa P; Marchini S; Veronesi U
    J Clin Oncol; 1983 Jan; 1(1):2-10. PubMed ID: 6366125
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conservative surgery and irradiation (QUART) in the treatment of 243 stage I-II breast cancer patients.
    Gasparini G; Panizzoni GA; Dal Fior S; Germani B; Dall'Antonia F; Segato G; Meli S; Pozza F
    Anticancer Res; 1991; 11(4):1635-40. PubMed ID: 1746920
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast cancer].
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):206-7. PubMed ID: 11355592
    [No Abstract]   [Full Text] [Related]  

  • 65. Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.
    Kaufmann M; Jonat W; Abel U; Hilfrich J; Caffier H; Kreienberg R; Trams G; Brunnert K; Schermann J; Kleine W
    J Clin Oncol; 1993 Mar; 11(3):454-60. PubMed ID: 8445420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study Group.
    Schmoor C; Bastert G; Dunst J; Bojar H; Christmann D; Unbehaun V; Tümmers G; Bauer W; Sauerbrei W; Schumacher M
    Int J Cancer; 2000 May; 86(3):408-15. PubMed ID: 10760830
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of postoperative and primary radiation therapy on delivered dose of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer.
    Levine JF; Coleman CN; Cox RS; Ray GR; Rogoway WM; Martinez A; Stockdale FE
    Cancer; 1984 Jan; 53(2):237-41. PubMed ID: 6546300
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Reduced-dose adjuvant CMF-chemotherapy combined with postoperative irradiation in breast cancer with lymphatic metastases. A prospective study of 45 patients].
    Sauerwein W; Nitz U; Rehwald U; Lapukins Z; Schmitt G; Scherer E
    Strahlentherapie; 1985 Jun; 161(6):354-61. PubMed ID: 3839325
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil.
    Miles DW; Harris WH; Gillett CE; Smith P; Barnes DM
    Int J Cancer; 1999 Aug; 84(4):354-9. PubMed ID: 10404085
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients.
    International Breast Cancer Study Group
    J Clin Oncol; 1996 Jun; 14(6):1885-94. PubMed ID: 8656257
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
    Bonadonna G; Rossi A; Valagussa P; Banfi A; Veronesi U
    Cancer; 1977 Jun; 39(6 Suppl):2904-15. PubMed ID: 326384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients.
    Zambetti M; Bonadonna G; Valagussa P; Daidone MG; Coradini D; Bignami P; Contesso G; Silvestrini R
    J Natl Cancer Inst Monogr; 1992; (11):77-83. PubMed ID: 1627434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adjuvant systemic therapy for operable breast cancer.
    Stewart HJ
    Br Med Bull; 1991 Apr; 47(2):343-56. PubMed ID: 1933218
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience.
    Leone JP; Leone J; Vallejo CT; Pérez JE; Romero AO; Machiavelli MR; Romero Acuña L; Domínguez ME; Langui M; Fasce HM; Leone BA; Ortiz E; Iturbe J; Zwenger AO
    Breast Cancer Res Treat; 2014 Jan; 143(2):313-23. PubMed ID: 24327333
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
    Bonadonna G; Valagussa P; Zambetti M; Brambilla C
    Recent Results Cancer Res; 1989; 115():113-7. PubMed ID: 2696023
    [No Abstract]   [Full Text] [Related]  

  • 77. The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma.
    Sulkes A; Brufman G; Rizel S; Weshler Z; Biran S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1983 Jan; 9(1):17-21. PubMed ID: 6687724
    [No Abstract]   [Full Text] [Related]  

  • 78. Adjuvant use of cytotoxic chemotherapy to destroy micrometastasis in breast cancer after local control therapy--current status.
    Carter SK
    Clin Exp Metastasis; 1983; 1(1):1-15. PubMed ID: 6399695
    [No Abstract]   [Full Text] [Related]  

  • 79. Perioperative adjuvant chemotherapy of breast cancer: the Scandinavian experience.
    Nissen-Meyer R; Host H; Kjellgren K; Mansson B; Norin T
    Recent Results Cancer Res; 1986; 103():95-102. PubMed ID: 3526478
    [No Abstract]   [Full Text] [Related]  

  • 80. Critical review of adjuvant therapy in premenopausal patients.
    Mouridsen HT
    Recent Results Cancer Res; 1989; 115():132-5. PubMed ID: 2623330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.